Table 2:

Type of first events by treatment group: NSABP B-42

	Placebo (n=1953)		Letrozole (n=1950)
First event	n	%	n	%
Distant recurrence	87	4.5	61	3.1
Local recurrence	33	1.7	36	1.8
Contralateral breast cancer	59	3.0	30	1.5
Second non-breast primaries	112	5.7	104	5.3
Death	48	2.5	61	3.1
Total first event	339	17.4	292	15.0
Alive, event free	1614	82.6	1658	85.0